Of note, recently, studies have described intrinsic effects of PD-L1 engagement in tumor cells through the mammalian target of rapamycin (mTOR) pathway, thus involving PD-L1 in metabolism, autophagy, cell growth and metastatic capability of tumor cells [94]. This evidence concerns the gene CD274 and neoplasm.